Merz Pharmaceuticals Belotero(R) Balance PMA Filing Formally Accepted For Review By The FDA
Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merzs premarket approval (PMA) application for Belotero(R) Balance.
Belotero(R) Balance is a hyaluronic acid based monophasic gel dermal filler that utilizes a cohesive polydensified matrix (CPM(TM)) technology. This application seeks FDA approval for injection into [...]